132 related articles for article (PubMed ID: 35481100)
1. Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468.
Mondal A; Shanavas S; Sen U; Das U; Roy N; Bose B; Paira P
RSC Adv; 2022 Apr; 12(19):11953-11966. PubMed ID: 35481100
[TBL] [Abstract][Full Text] [Related]
2. Iridium(III)-Cp*-(imidazo[4,5-
Kar B; Shanavas S; Nagendra AH; Das U; Roy N; Pete S; Sharma S A; De S; Kumar S K A; Vardhan S; Sahoo SK; Panda D; Shenoy S; Bose B; Paira P
Dalton Trans; 2022 Apr; 51(14):5494-5514. PubMed ID: 35293923
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear Luminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic Agents.
Roy N; Sen U; Madaan Y; Muthukumar V; Varddhan S; Sahoo SK; Panda D; Bose B; Paira P
Inorg Chem; 2020 Dec; 59(23):17689-17711. PubMed ID: 33210921
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria specific highly cytoselective iridium(iii)-Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents.
Roy N; Sen U; Ray Chaudhuri S; Muthukumar V; Moharana P; Paira P; Bose B; Gauthaman A; Moorthy A
Dalton Trans; 2021 Feb; 50(6):2268-2283. PubMed ID: 33507192
[TBL] [Abstract][Full Text] [Related]
5. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
Dalton Trans; 2024 Jun; ():. PubMed ID: 38899369
[TBL] [Abstract][Full Text] [Related]
6. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Effects of Ir(III)-2
Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
[TBL] [Abstract][Full Text] [Related]
8. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro.
Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032
[TBL] [Abstract][Full Text] [Related]
10. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
[TBL] [Abstract][Full Text] [Related]
11. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
12. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
13. Exploring the phototoxicity of GSH-resistant 2-(5,6-dichloro-1
Das U; Paira P
Dalton Trans; 2024 Apr; 53(14):6459-6471. PubMed ID: 38512047
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
[TBL] [Abstract][Full Text] [Related]
15. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
[TBL] [Abstract][Full Text] [Related]
16. A novel indenone derivative selectively induces senescence in MDA-MB-231 (breast adenocarcinoma) cells.
Priyanga J; Sharan Kumar B; Mahalakshmi R; Nirekshana K; Vinoth P; Sridharan V; Bhakta-Guha D; Guha G
Chem Biol Interact; 2020 Nov; 331():109250. PubMed ID: 32956706
[TBL] [Abstract][Full Text] [Related]
17. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.
Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z
Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698
[TBL] [Abstract][Full Text] [Related]
18. Cyclometalated Iridium(III) Complexes as Two-Photon Phosphorescent Probes for Specific Mitochondrial Dynamics Tracking in Living Cells.
Jin C; Liu J; Chen Y; Zeng L; Guan R; Ouyang C; Ji L; Chao H
Chemistry; 2015 Aug; 21(34):12000-10. PubMed ID: 26215253
[TBL] [Abstract][Full Text] [Related]
19. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
